Product Information
ZERVIATE 0.24% EYE DROP is a brand product labeled by Harrow Eye, LLC, priced at $7.3532 per EA under NDC 82667001524. Its NADAC has been published 34 times since Nov 5, 2025.
Strength
2.4 mg/mL
Manufacturer
Harrow Eye, LLCNDC
82667001524
Classification
Brand
Dosage Form
FOR SOLUTION
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
CETIRIZINEApproval Type
New Drug (NDA)
FDA Application
NDA208694On Market Since
4/30/2025
Pharmacological Classes
Price Statistics
The NADAC for ZERVIATE 0.24% EYE DROP has been published 34 times since Nov 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.3532 per EA |
|---|---|
| All-time high | $7.3532 (Jun 24, 2026) |
| All-time low | $7.3243 (Apr 22, 2026) |
| 52-week high | $7.3532 |
| 52-week low | $7.3243 |
| Median price | $7.3519 |
| Average price | $7.3442 |
| Largest weekly change | +0.3% (Jun 17, 2026) |
| Weeks tracked | 34 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the cetirizine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ZERVIATE 0.24% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for ZERVIATE 0.24% EYE DROP, manufactured by Harrow Eye, LLC, is $7.3532 per EA (NDC 82667001524), effective Jun 24, 2026.
How has the price of ZERVIATE 0.24% EYE DROP changed over time?
Over the history we have for it, the NADAC for ZERVIATE 0.24% EYE DROP has held within roughly two percent of its current level. It has been tracked across 34 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for ZERVIATE 0.24% EYE DROP?
Since Nov 5, 2025, the NADAC for ZERVIATE 0.24% EYE DROP has ranged from a low of $7.3243 (Apr 22, 2026) to a high of $7.3532 (Jun 24, 2026), with a median of $7.3519 per EA.
Are there cheaper alternatives to ZERVIATE 0.24% EYE DROP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ZERVIATE 0.24% EYE DROP, so no direct lower-cost alternative is listed.
Who manufactures ZERVIATE 0.24% EYE DROP?
ZERVIATE 0.24% EYE DROP (NDC 82667001524) is labeled by Harrow Eye, LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification